| Entry |
|
|---|
| Name |
Barbital (JP17/INN);
Barbital (TN)
|
|---|
| Formula |
C8H12N2O3
|
|---|
| Exact mass |
184.0848
|
|---|
| Mol weight |
184.1925
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Class |
Neuropsychiatric agent
DG01837 Barbiturate sedative-hypnotics
DG01567 GABA-A receptor agonist
|
|---|
| Remark |
|
|---|
| Efficacy |
Sedative-hypnotic |
|---|
| Comment |
Barbiturates
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07230 | GABA-A receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CA Barbiturates, plain
N05CA04 Barbital
D01740 Barbital (JP17/INN)
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D01740 Barbital (JP17/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01740 Barbital
Drug classes of therapeutic agents [br08360.html]
Psychiatric agents
D01740
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 13
1 C1z C 21.9896 -17.3559
2 C5x C 21.9896 -18.7559
3 C5x C 20.7763 -16.6558
4 C1b C 23.3780 -17.3559
5 C1b C 21.9838 -15.9616
6 N1x N 20.7763 -19.4617
7 O5x O 23.2030 -19.4617
8 N1x N 19.5571 -17.3559
9 O5x O 20.7763 -15.2558
10 C1a C 24.0663 -16.1483
11 C1a C 23.1971 -15.2615
12 C5x C 19.5571 -18.7559
13 O5x O 18.3438 -19.4617
BOND 13
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 2 7 2
7 3 8 1
8 3 9 2
9 4 10 1
10 5 11 1
11 6 12 1
12 12 13 2
13 8 12 1
|
|---|
